|
Abstract
Aim: Atopic dermatitis
(eczema) is a chronic inflammatory skin condition with a strong genetic
basis. Despite genome-wide association studies (GWAS) identifying associated
regions, the underlying genetic profile and pathological mechanisms remain
incompletely elucidated. This study aimed to characterise key genetic
variants and their functional significance in atopic dermatitis.
Methodology: GWAS data for
atopic dermatitis were analysed to identify key genetic variants. Functional
relevance among candidate genes was assessed through pathway enrichment,
protein–protein interaction, and clustering analyses. Regulatory mechanisms
were explored via miRNA and transcription factor interaction mapping, whilst
metabolomic data integration linked genetic variation to immune dysregulation
and skin barrier dysfunction.
Results: Key loci
implicating genes involved in immune response and epithelial barrier function
were identified. Enrichment analyses highlighted mitochondrial biology, lipid
metabolism, and cytokine signalling pathways. MicroRNAs and transcription
factors were implicated as regulatory contributors to disease pathogenesis,
and metabolomic validation confirmed detectable effects on immune-related
functions and skin homeostasis.
Interpretation: These findings
reinforce the genetic aetiology of atopic dermatitis, identifying novel loci
and advancing understanding of its pathophysiology. The therapeutic targets
emerging from this integrative analysis may serve as foundation for future
personalised medicine approaches.
Key
words:
Atopic dermatitis, Genetic predisposition, Genome-wide association study,
Inflammatory pathways, Skin barrier dysfunction
|